Find and compare companies providing:
Contract pharmaceutical outsourcing services
Filter by expertise, certification, scale and geography to shortlist trusted contract pharmaceutical service providers for effective pharma outsourcing.
Filters
Production region
Production scale
Qualifications
Follow us
Plants in:
Established in: 1886
Production scale:
medium
small
Employees: 275+
Raw materials, CMO and OTC products
Two GMP certified locations
Customisable (small-sized) packages
All certificates
Replies quickly
Specialized in complex product development and manufacturing.
High-quality standards with a focus on customer-specific needs.
Agile and innovative approach to CDMO services.
All certificates
Replies quickly
Plants in:
Established in: 1975
Production scale:
small
medium
large
Employees: 234
45+ years of experience in oral solid and nonsterile oral liquid
Specialization in pediatric, geriatric, and controlled-substance
Reliable and flexible full-service production partner
All certificates
Replies quickly
Plants in:
Established in: 2023
Production scale:
small
medium
large
Employees: 1000+
Expertise in Conventional, Complex, and Niche Chemistries
End-to-end Support from early development to Commercial Phases
Comprehensive Analytical Support Facilities
All certificates
Replies quickly
Plants in:
Established in: 2008
Production scale:
large
small
medium
Employees: 4.000
With 14 production sites in Europe and the USA
7 Development Centers of Excellence covering all dosage forms
13 locations with Technology Services on site for seamless Tech Transfer and product Life-Cycle Management
All certificates
Replies quickly
Plants in:
Established in: 1998
Production scale:
small
medium
large
Employees: 1000
Facilities with global regulatory compliance
Customized and Flexible Collaboration Models
End-to-end drug discovery
All certificates
Replies quickly
All certificates
Replies quickly
Plants in:
Established in: 2019
Production scale:
large
Employees: 10+
Focused on pharmaceutical industry
Reasonable price for the customers
Full service from R&D stage to commercial stage
All certificates
Replies quickly
Plants in:
Established in: 2012
Production scale:
medium
Employees: 180
A high-tech enterprise with 13 own patents granted
Strong R&D system with ISO9001 / ISO14001 / OHSAS18001 certification
Provide professional CMO & CDMO service
All certificates
Replies quickly
Plants in:
Established in: 2003
Production scale:
large
Employees: 4000+
20+ years’ expertise in API manufacturing, trusted for quality and global compliance.
Listed pharma leader in China, prioritizing transparency and regulatory excellence.
End-to-end integration from R&D to scalable production, delivering cost-efficient solutions.
All certificates
Replies quickly
Plants in:
Established in: 1972
Production scale:
medium
Employees: 1,000+
EU-GMP for APIs and CEP for certain APIs
Exporting to over 50 countries worldwide
Long-standing technological advantage in adamantane, quinuclidine and nitrofurane chemistry
All certificates
Replies quickly
Plants in:
Established in: 1997
Production scale:
small
medium
Employees: 140
Top-tier adherence to global pharmaceutical standards including GMP, FDA and EMA
Specialized advanced chemistry laboratory focused on upscaling and GMP transfer processes
Comprehensive analytical services to meet precise client specifications.
All certificates
Replies quickly
Plants in:
Established in: 2008
Production scale:
large
medium
Employees: 300+
More than 150 patents based on independent intelligence
Expertise in anti-tumor, anti-diabetes and cardiovascular API and intermediates.
GMP facility with annual production capacity of 300M
All certificates
Replies quickly
Plants in:
Established in: 1955
Production scale:
small
medium
large
Employees: 500+
BFS expertise with FDA Approval for Sterile Manufacturing
USA and European Quality
Innovative solutions for ophthalmology and otorhinolaryngology
All certificates
Replies quickly
Plants in:
Established in: 1989
Production scale:
large
Employees: 5000+
6 production facilities approved by USFDA, AGES-Austria, PMDA, WHO
R&D Centers with capabilities of ANDAs, DMFs and NDDS
462+ patents filed for drug substances and polymorphs
All certificates
Replies quickly
Plants in:
Established in: 1964
Production scale:
small
medium
large
Employees: 135+
Market leader in Switzerland
Small and medium batch sizes
Pharmaceutical raw materials with a herbal or synthetic basis
All certificates
Replies quickly
Plants in:
Established in: 2021
Production scale:
small
Employees: 19
API, Intermediates, Building Blocks, Impurities, Amino acids and Peptides
Small quantity APIs to commercial scale
GMP and USFDA certification based on quantity, order, assignment.
All certificates
Replies quickly
Plants in:
Established in: 1980
Production scale:
medium
Employees: 30+
EU-GMP and DIN EN ISO 9001:2015
Pioneer in the fractionation of sheep plasma
Pure & sterile high-quality products
All certificates
Replies quickly
Plants in:
Established in: 1993
Production scale:
large
Employees: 75
Clinically proven efficacy
Highest safety profile
In-depth scientific & regulatory support
All certificates
Replies quickly
Plants in:
Established in: 2013
Production scale:
medium
Employees: 25+
ISO9001 certified
Drug R&D center (in Hangzhou)
From lab scale (mg/g) to commercial scale (kgs/tons)
All certificates
Replies quickly
Plants in:
Established in: 1991
Production scale:
small
medium
large
Employees: 3,500+
More than 12 GMP manufacturing facilities (EU, US, India)
Portfolio of more than 240 commercial APIs
We are experts in the cGMP production of highly potent compounds
All certificates
Replies quickly
15 years of experience in synthetic chemistry, PhD & Master up to 50 employees
Logistics advantage: global customers can be delivered within 2-7 working days
Confidentiality Assured: With confidentiality clauses to ensure customer data security
All certificates
Replies quickly
Plants in:
Established in: 1987
Production scale:
medium
small
large
Employees: 50+
ISO 9001:2015 & SGS audited supplier
One-stop CDMO Solutions for APl and Key intermediates
Specialized in APIs & Pharmaceutical Intermediates for 38 years
All certificates
Replies quickly
Plants in:
Established in: 1951
Production scale:
medium
Employees: 455+
Largest Polish manufacturer of pharmaceuticals and a leader of the Polish pharmaceutical market.
FDA approved european manufcaturing facilities
Export APIs to more than 60 countries worldwide
All certificates
Replies quickly
Plants in:
Established in: 1934
Production scale:
large
small
medium
Employees: 1500
Full-Service CDMO with End-to-End Solutions
Reliable Global Distribution Operating in over 70 countries
Specialized in hormones, crystal-suspensions and complex injectables
All certificates
Replies quickly
Plants in:
Established in: 2022
Production scale:
large
Employees: 50
Complex Chemistry Expertise – 30+ advanced chemistries backed by a strong R&D team
End-to-End Molecule Development from Idea to Commercial Scale
Global Quality, India Advantage – cGMP/FDA-compliant facilities, world-class SHE & IP standard at effecient pricing
All certificates
Replies quickly
Plants in:
Established in: 1952
Production scale:
small
medium
large
Employees: 550+
API manufacturing (Innovators, Generics and Highly Potent)
A tailor-made and flexible service approach
State-of-the-art analytical services including solid form and QbD laboratories
All certificates
Replies quickly
Plants in:
Established in: 2006
Production scale:
small
medium
Employees: 20
Quality Assurance: Products are manufactured from the finest raw materials and undergo rigorous testing.
Tailored Customisation & Compliance: Providing end-to-end solutions to meet your business
Dependable Expertise and Supply: Backed by years of industry experience and a robust supply chain.
All certificates
Replies quickly
Plants in:
Established in: 2011
Production scale:
small
Employees: 50+
Comprehensive Product Portfolio with Competitive Pricing.
Focus on Quality and Regulatory Compliance, One-stop, Responsive, End-to-End Service from R&D Through Commercialization.
Expertise and Reliability in Pharmaceutical Material Supply, Backed by a Singaporean Presence.
All certificates
Replies quickly
Plants in:
Established in: 2016
Production scale:
medium
small
Low Volume high value API Fill and Finish Service
In-line monitoring, SKAN Isolators, Highly Experienced Staff
Capacity Available, Ready for your API
All certificates
Replies quickly
Plants in:
Established in: 2006
Production scale:
small
medium
large
Employees: 3500
Silver EcoVadis awardee committed to sustainability
Exceptional synthesis experience of HPAPIs
One-stop CDMO Solutions for APl and Key intermediates
All certificates
Replies quickly
Plants in:
Established in: 2016
Production scale:
small
medium
large
Employees: 200
PFAS-Free Peptides
Certified Quality & Sustainability with ISO 9000 certification and RSPO audited supplier & GMP
Specialized in APIs & Pharmaceutical Intermediates
All certificates
Replies quickly
Plants in:
Established in: 1965
Production scale:
small
medium
large
Employees: 600+
Pharmaceutical-quality dextrans meeting the highest standards and complying with major pharmacopeias
Manufactured in a cGMP facility in Denmark, inspected by both the FDA and EMA
Documented quality and certifications from the US FDA and EDQM for smooth regulatory submission
All certificates
Replies quickly
Plants in:
Established in: 2005
Production scale:
medium
small
Employees: 200+
Portfolio of over 2,000 APIs
Precise quality control
End-to-end global regulatory support
All certificates
Replies quickly
Plants in:
Established in: 2014
Production scale:
small
medium
large
Employees: 1000+
24 years of production experience
6 workshops and 9 production lines which has 100t/month production capacity
4 USDMFS & 8 CEPS & 200+ Patents
All certificates
Replies quickly
Plants in:
Established in: 1982
Production scale:
small
Employees: 30+
Modern GMP facility
Team of academics and technical experts
Small to large batch sizes possible
All certificates
Replies quickly
Certified by US FDA
Well-Established Environmental, Health & Safety Protocols
Seasoned Project Execution Team
All certificates
Replies quickly
Plants in:
Established in: 1993
Production scale:
small
medium
large
Employees: 600
Integrated innovative platforms for Technology Transfer (TT&GO®)
Fermentation, purification, and chemical synthesis technologies on the same site
Scalability from Laboratory and Pilot to Industrial scales
All certificates
Replies quickly
Expertise in cell therapy development and manufacturing.
Tailored solutions for autologous and allogeneic cell therapies.
Cutting-edge technology for scalable and efficient cell therapy production.
All certificates
Replies slower than most
Innovator in blow-fill-seal technology for sterile liquid dosages.
Expertise in unit dose packaging for ophthalmics and respiratory solutions.
State-of-the-art facilities ensuring precision and scalability.
All certificates
Replies slower than most
Strong heritage in pharmaceutical innovation and biotechnology.
Comprehensive range of services from early development to commercial supply.
Focus on quality, reliability, and sustainability in biopharmaceutical manufacturing.
All certificates
Replies slower than most
Leaders in dermatological product development and testing.
Innovative solutions for skin permeation and absorption studies.
Strong focus on client-centric, scientifically driven services.
All certificates
Replies slower than most
Plants in:
Established in: 1996
Production scale:
large
small
medium
Leading in biopharmaceutical development and biologic API production.
Comprehensive services from cell line development to commercial manufacturing.
Strong track record in delivering complex and high-quality biologics.
All certificates
Replies quickly
Plants in:
Established in: 2023
Production scale:
medium
Employees: 34
Ensures stability across batches from gene editing to enzyme and UDCA production
GMP standards compliance to ensure the lowest levels of single, total, and C impurities within the product category
Customized services, supplying enzymes for UDCA conversion and crude UDCA products with purity from 85% to 99.99%
All certificates
Replies quickly
Comprehensive drug development services from molecule to market.
Expertise in nanomedicine and drug repurposing.
Tailored project management ensuring efficiency and transparency.
All certificates
Replies slower than most
Excellence in aseptic filling and packaging solutions for biologics.
Customized solutions for pre-filled syringes, vials, and cartridges.
Strong track record in supporting global market launches.
All certificates
Replies slower than most
Pioneering in advanced delivery technologies and development solutions.
Extensive global network ensuring supply chain resilience.
Tailored services across biologics, gene therapies, and pharmaceuticals.
All certificates
Replies slower than most
Specialized in liquid and semi-solid pharmaceuticals manufacturing.
Nordic excellence in quality and reliability.
Flexible production capabilities catering to a wide range of batch sizes.
All certificates
Replies slower than most
Specialized in sterile ophthalmic and injectable formulations.
Focus on flexibility and customization for client-specific needs.
Advanced manufacturing capabilities in a controlled environment.
All certificates
Replies slower than most
Plants in:
Established in: 2002
Production scale:
large
Specialized in biologics CDMO services with a focus on monoclonal antibodies.
Advanced facilities for clinical and commercial-scale manufacturing.
Strong commitment to quality and regulatory compliance.
All certificates
Replies slower than most
Plants in:
Established in: 1942
Production scale:
large
Over 100 unique marketed pharmaceutical products and 17 approved product applications since 2019
Manufacturing capacities : 3.5B Oral Solid doses and 2.0M liters of liquids per year
We specialize in contract manufacturing of Oral Solid Dose (OSD) and Liquids, including high potency substances and small molecules.
All certificates
Replies slower than most
Expertise in ophthalmic drug delivery solutions.
Committed to high-quality standards and patient safety.
Innovative R&D for advanced ophthalmic formulations.
All certificates
Replies slower than most
Plants in:
Established in: 1962
Production scale:
large
500 millions of lozenges per year at the Aignan site
143 million packs per year at the Gien site
252 formulations per year at the Cahors site
All certificates
Replies slower than most
Specialized in sterile and non-sterile pharmaceutical manufacturing.
Focus on flexibility and customization for client-specific needs.
State-of-the-art technology ensuring quality and efficiency.
All certificates
Replies slower than most
Successfully inspected by TGA, PMDA, MHRA, ANVISA, Health Canada, MPA, IMB, & FDA
All facilities are in good standing with all regulatory authorities, including DEA, EPA, OSHA
Quality Management System and supporting analytical processes are almost 100% electronic
All certificates
Replies quickly
Dedicated to high-quality ophthalmic and ENT product manufacturing.
Emphasis on natural and gentle formulations for sensitive applications.
Italian excellence in innovative product development and production.
All certificates
Replies slower than most
Leading global provider of plasma-derived medicines.
Strong focus on innovation in bioscience solutions.
Comprehensive services from plasma collection to finished product.
All certificates
Replies slower than most
Advanced polymers technology for optimized drug delivery systems.
Global capabilities in complex formulations and specialty chemicals.
Emphasis on collaborative partnerships for innovative solutions.
All certificates
Replies slower than most
Plants in:
Established in: 2013
Production scale:
small
medium
Employees: 50
Custom Fermentation Solutions, Strain Selection & Development
Process optimization to maximize yield, efficiency, and product quality
Support and scale-up expertise with consistent and reliable results each stage
All certificates
Replies quickly
Leading in aerosol and transdermal drug delivery systems.
Expertise in both small molecule and biologic drug formulation.
Strong track record in bringing complex therapies to market.
All certificates
Replies slower than most
What is a CDMO, CMO, and CRO?
Outsourcing terms are often used interchangeably, but they describe different scopes. This page is a directory for CDMO services and CMO services, with guidance to help you route correctly.
CDMO
Development + manufacturing: process development, scale-up, tech transfer, validation, and GMP production.
CMO
Manufacturing execution: GMP manufacturing, packaging, and supply continuity once the process is established.
CRO
Research and clinical support: analytical/bioanalytical work, clinical services, and research-heavy deliverables.
Practical rule: ignore the label and validate the scope (what’s in-house, what’s routine for them, and what they can support at your stage).
How to choose the right outsourcing model
Browsing suppliers is the easy part. Choosing the right outsourcing setup is where projects win or stall. Use the sections below to route correctly and approach suppliers with clear requirements.
Decision tree: where should you start?
This is a practical routing checklist (not a textbook). Use it to avoid contacting the wrong type of supplier.
What are you outsourcing?
Active ingredient / API / upstream manufacturing → start with Drug Substance (CDMO/CRO)
Finished dosage form / fill-finish / packaging → start with Drug Product (CMO)Do you need development or only manufacturing?
Development + manufacturing → shortlist CDMO services
Manufacturing only (process already defined) → shortlist CMO servicesAny specialized constraints?
Sterile manufacturing, high potency/containment (OEB), cold chain, controlled substances → shortlist specialized facilities firstWhich stage are you in?
Early development / clinical → flexibility, small batches, fast iteration
Commercial → capacity, quality maturity, supply reliability, documentation readiness
How outsourcing typically works
A smooth outsourcing project is mostly about clarity and preparation. These steps help you move faster and reduce rework.
Define requirements (product type, stage, markets, batch sizes, timelines)
Build a shortlist (capability fit + region + quality requirements)
Share a concise project brief (and sign an NDA if needed)
Feasibility & proposal (timeline, costs, risks, required inputs)
Quality assessment (documentation review, audit readiness)
Agreement setup (quality agreement, responsibilities, change control)
Tech transfer (process, analytics, materials, packaging components)
Validation & routine supply (as required by stage and markets)
Supplier evaluation checklist
Suppliers respond faster and more accurately when your brief is clear. Use this checklist before outreach.
What to prepare before contacting suppliers
- Product type (Drug Substance / Drug Product) and dosage form (if applicable)
- Development stage (preclinical / clinical / commercial)
- Batch sizes and annual demand estimate
- Target markets (EU/US/other) and quality expectations (GMP, documentation)
- Key constraints (sterile, containment/OEB, cold chain, controlled substances)
- Timeline (tech transfer, first batch, launch window)
Questions to ask during evaluation
- Capability & experience: similar products? similar scales? which steps are in-house?
- Quality & compliance: inspections/markets supported, CAPA/change control maturity
- Capacity & timelines: realistic lead times, bottlenecks, mitigation plan
- Communication: ownership, cadence, escalation, documentation standards
RFQ template: what to include in your first message
If your first message is vague, quotes will be vague. Include the items below to speed up proposals.
- Scope: Drug Substance or Drug Product; development needed or manufacturing only
- Stage: clinical vs commercial; target markets (FDA/EMA/others)
- Volumes: batch sizes + annual demand estimate
- Constraints: sterile, containment/OEB, cold chain, controlled substances
- Timeline: desired start date, first batch, launch window
- Quality: required certifications, audit expectations, documentation level
FAQ: CDMO & CMO outsourcing
Quick answers for common sourcing questions. If you’re unsure, use the open inquiry option above and include your constraints.
Should I choose a CDMO or a CMO?
Choose a CDMO when you need development work (process development, scale-up, tech transfer support) along with manufacturing. Choose a CMO when your process is established and you mainly need manufacturing execution and supply.
What is the difference between Drug Substance and Drug Product?
Drug Substance is the active ingredient (API). Drug Product is the finished dosage form patients use (tablets, capsules, injectables, sprays, creams, etc.).
When should I involve a CRO?
Involve a CRO when your scope includes research-heavy work (bioanalysis, clinical services, specialized analytical tasks). Some CDMOs also provide CRO-like services; validate what’s truly in-house.
Can one supplier handle both Drug Substance and Drug Product?
Sometimes yes, but many suppliers specialize. The fastest approach is usually to shortlist based on the exact stage and manufacturing scope you need now, then expand if you want a single long-term partner.
How do I shortlist suppliers quickly without missing a good option?
Start with scope (Drug Substance vs Drug Product), then filter by constraints (sterile, containment/OEB), target markets (FDA/EMA), and scale (batch size). Only then compare “nice-to-haves.”
What affects price the most in outsourcing quotes?
The biggest drivers are development effort, complexity (sterile/containment), batch size, analytical requirements, validation scope, and documentation/market requirements. Clear inputs reduce pricing uncertainty.
Do I need an NDA before contacting a CDMO/CMO?
Often yes if you need to share sensitive details. Many suppliers can review a high-level brief without an NDA, then sign one before detailed transfer.
How do I verify GMP capabilities?
Check relevant certifications/inspections for your target markets, ask what’s in-scope at the specific facility, and validate quality systems (deviations/CAPA, change control, batch record/release workflow). Audits are common for final confirmation.
How long does it take to onboard a new outsourcing partner?
It depends on stage and complexity. Expect time for feasibility, quality assessment, agreements, and tech transfer. Sterile, high potency, or complex biologics typically require longer lead times.
What should I include in an open inquiry to get better matches?
Include product type (Drug Substance/Drug Product), stage, markets, batch sizes, key constraints (sterile/OEB/cold chain), and timeline. The more specific you are, the fewer irrelevant matches you get.
